Kiwa Bio-Tech Products Group Corporation
KWBT · OTC
12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | |
|---|---|---|---|---|
| Market Cap | $456 | $8,261 | $20,944 | $5,936 |
| - Cash | $8 | $8 | $1,084 | $13 |
| + Debt | $2,892 | $1,331 | $1,093 | $2,166 |
| Enterprise Value | $3,340 | $9,584 | $20,954 | $8,088 |
| Revenue | $40,089 | $30,650 | $17,270 | $9,618 |
| % Growth | 30.8% | 77.5% | 79.6% | – |
| Gross Profit | $9,332 | $8,258 | $5,424 | $1,945 |
| % Margin | 23.3% | 26.9% | 31.4% | 20.2% |
| EBITDA | -$983 | $2,616 | $2,225 | $1,604 |
| % Margin | -2.5% | 8.5% | 12.9% | 16.7% |
| Net Income | -$6,635 | $344 | $5,309 | $963 |
| % Margin | -16.6% | 1.1% | 30.7% | 10% |
| EPS Diluted | -0.29 | 0.021 | 0.43 | 0.09 |
| % Growth | -1,494.2% | -95.2% | 377.8% | – |
| Operating Cash Flow | $183 | -$1,649 | -$5,649 | -$1,143 |
| Capital Expenditures | $0 | -$53 | -$75 | -$79 |
| Free Cash Flow | $183 | -$1,702 | -$5,724 | -$1,222 |